Adams Diversified Equity Fund, Inc. Abb Vie Inc. Transaction History

Adams Diversified Equity Fund, Inc.

$2.69 Billion
Q3 2024

A detailed history of Adams Diversified Equity Fund, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Adams Diversified Equity Fund, Inc. holds 199,000 shares of ABBV stock, worth $34.9 Million. This represents 1.46% of its overall portfolio holdings.

Number of Shares

199,000

Previous 222,200 10.44%

Holding current value

$34.9 Million

Previous $38.1 Million 3.11%

% of portfolio

1.46%

Previous 1.31%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$163.84 - $199.33 $3.8 Million - $4.62 Million	-23,200 Reduced 10.44%	199,000 $39.3 Million
Q2 2024 Aug 01, 2024	BUY	$154.79 - $180.76 $6.53 Million - $7.63 Million	42,200 Added 23.44%	222,200 $38.1 Million
Q1 2024 Apr 24, 2024	BUY	$159.82 - $182.1 $28.8 Million - $32.8 Million	180,000 New	180,000 $32.8 Million
Q1 2023 Apr 26, 2023	BUY	$144.61 - $166.54 $7.3 Million - $8.41 Million	50,476 Added 39.04%	179,776 $28.7 Million
Q4 2022 Feb 03, 2023	BUY	$138.31 - $165.87 $6.29 Million - $7.55 Million	45,500 Added 54.3%	129,300 $20.9 Million
Q3 2022 Oct 26, 2022	SELL	$134.21 - $153.93 $4.56 Million - $5.23 Million	-34,000 Reduced 28.86%	83,800 $11.2 Million
Q2 2022 Jul 27, 2022	SELL	$137.62 - $174.96 $13.6 Million - $17.3 Million	-98,800 Reduced 45.61%	117,800 $18 Million
Q1 2022 Apr 27, 2022	SELL	$131.98 - $163.75 $13.5 Million - $16.8 Million	-102,600 Reduced 32.14%	216,600 $35.1 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $11.9 Million - $15.1 Million	111,200 Added 53.46%	319,200 $43.2 Million
Q3 2021 Oct 27, 2021	SELL	$106.4 - $120.78 $12.2 Million - $13.8 Million	-114,200 Reduced 35.44%	208,000 $22.4 Million
Q2 2021 Jul 23, 2021	BUY	$105.21 - $117.21 $8.55 Million - $9.53 Million	81,300 Added 33.75%	322,200 $36.3 Million
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $3.24 Million - $4.37 Million	-40,200 Reduced 14.3%	240,900 $25.8 Million
Q3 2020 Oct 20, 2020	BUY	$85.91 - $100.83 $5.64 Million - $6.61 Million	65,600 Added 30.44%	281,100 $24.6 Million
Q2 2020 Jul 23, 2020	SELL	$73.37 - $98.18 $7.87 Million - $10.5 Million	-107,200 Reduced 33.22%	215,500 $21.2 Million
Q4 2019 Jan 31, 2020	BUY	$72.13 - $90.25 $23.3 Million - $29.1 Million	322,700 New	322,700 $28.6 Million
Q3 2018 Oct 29, 2018	SELL	$88.91 - $98.84 $23.6 Million - $26.3 Million	-265,700 Closed	0 $0
Q1 2018 Apr 27, 2018	SELL	$92.01 - $123.21 $5.29 Million - $7.08 Million	-57,500 Reduced 17.79%	265,700 $25.1 Million
Q4 2017 Feb 13, 2018	SELL	$89.56 - $98.21 $5.09 Million - $5.58 Million	-56,800 Reduced 14.95%	323,200 $31.3 Million
Q3 2017 Oct 30, 2017	BUY	$69.85 - $89.22 $26.5 Million - $33.9 Million	380,000	380,000 $33.8 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adams Diversified Equity Fund, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Adams Diversified Equity Fund, Inc. with notifications on news.

Account

Adams Diversified Equity Fund, Inc. Abb Vie Inc. Transaction History